Clinical Trial Update: Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma

View source ↗

Summary

This clinical trial update notes recruitment for a neoadjuvant therapy study combining carboplatin and paclitaxel with an anti-PD-1 drug in patients with resect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Anti-PD-1 inhibitor
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Head and Neck Squamous Cell Carcinoma | Status: RECRUITING